Journey Medical sells prescription skin treatments for acne, rosacea and excessive underarm sweating in the United States. DERM reports earnings on Wed, Nov 11, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 25 | Rodman & Renshaw | Initiated | Buy | |
| Aug 13 | B. Riley Securities | Reiterated | Buy |
Seasonality
How DERM has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
Whale Options Flow
90DNo whale options trades in DERM in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DERM is in one of them and how their past DERM trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered DERM in an article yet. Here's the latest on the wider market.
About Journey Medical
Journey Medical sells prescription medicines for skin conditions in the United States. Its main products treat acne, rosacea and excessive underarm sweating, and include brands such as Emrosi, Qbrexza, Accutane and Zilxi. The company also sells older skin and wound care products. It is based in Scottsdale, Arizona, and its sales team markets its products to doctors who prescribe them to patients.
- Headquarters
- Scottsdale, AZ